Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgery | 3 | 2024 | 35 | 1.260 |
Why?
|
| Spinal Fusion | 8 | 2022 | 231 | 0.990 |
Why?
|
| Cervical Vertebrae | 4 | 2022 | 132 | 0.860 |
Why?
|
| Internal Fixators | 2 | 2021 | 35 | 0.720 |
Why?
|
| Skull Base | 1 | 2020 | 46 | 0.680 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 78 | 0.660 |
Why?
|
| Students, Medical | 1 | 2024 | 323 | 0.640 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 234 | 0.430 |
Why?
|
| Meningioma | 2 | 2023 | 82 | 0.390 |
Why?
|
| Postoperative Complications | 5 | 2022 | 2475 | 0.390 |
Why?
|
| Meningeal Neoplasms | 2 | 2023 | 94 | 0.390 |
Why?
|
| Radiculopathy | 2 | 2022 | 33 | 0.350 |
Why?
|
| Spinal Cord Diseases | 2 | 2021 | 40 | 0.340 |
Why?
|
| Glioma | 2 | 2025 | 351 | 0.330 |
Why?
|
| Brain Neoplasms | 3 | 2025 | 1149 | 0.310 |
Why?
|
| Lumbosacral Region | 3 | 2022 | 55 | 0.270 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2018 | 155 | 0.260 |
Why?
|
| Dexamethasone | 2 | 2018 | 347 | 0.240 |
Why?
|
| Treatment Outcome | 11 | 2025 | 10232 | 0.240 |
Why?
|
| Neurosurgical Procedures | 2 | 2023 | 168 | 0.210 |
Why?
|
| Synovial Cyst | 1 | 2022 | 3 | 0.210 |
Why?
|
| Opiate Alkaloids | 1 | 2022 | 6 | 0.200 |
Why?
|
| Chyle | 1 | 2022 | 4 | 0.200 |
Why?
|
| Cell Movement | 2 | 2017 | 942 | 0.200 |
Why?
|
| Spheroids, Cellular | 3 | 2018 | 76 | 0.200 |
Why?
|
| Pseudarthrosis | 1 | 2022 | 11 | 0.200 |
Why?
|
| Spinal Diseases | 1 | 2022 | 47 | 0.190 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2022 | 39 | 0.180 |
Why?
|
| Hernia | 1 | 2021 | 10 | 0.180 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2021 | 33 | 0.180 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 56 | 0.180 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2020 | 17 | 0.170 |
Why?
|
| Atlanto-Axial Joint | 1 | 2020 | 13 | 0.170 |
Why?
|
| Cavernous Sinus | 1 | 2020 | 17 | 0.170 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2020 | 9 | 0.170 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 34 | 0.170 |
Why?
|
| Myotomy | 1 | 2020 | 11 | 0.170 |
Why?
|
| Machine Learning | 1 | 2025 | 441 | 0.160 |
Why?
|
| Clinical Competence | 2 | 2024 | 1015 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 107 | 0.160 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 261 | 0.160 |
Why?
|
| Radial Artery | 1 | 2019 | 69 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2023 | 14532 | 0.160 |
Why?
|
| Bone Screws | 1 | 2020 | 113 | 0.160 |
Why?
|
| Humans | 26 | 2025 | 129527 | 0.160 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 77 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2020 | 105 | 0.150 |
Why?
|
| Spinal Cord Compression | 1 | 2018 | 18 | 0.150 |
Why?
|
| Spinal Neoplasms | 1 | 2018 | 29 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 95 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 2018 | 26 | 0.150 |
Why?
|
| Disabled Persons | 1 | 2020 | 138 | 0.150 |
Why?
|
| Surgeons | 1 | 2022 | 264 | 0.150 |
Why?
|
| Joint Instability | 1 | 2020 | 166 | 0.150 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 133 | 0.150 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 207 | 0.150 |
Why?
|
| Calreticulin | 1 | 2018 | 27 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2020 | 507 | 0.140 |
Why?
|
| Glioblastoma | 2 | 2018 | 322 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 84 | 0.140 |
Why?
|
| Diphenylamine | 1 | 2017 | 9 | 0.140 |
Why?
|
| Disease Management | 1 | 2021 | 591 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 715 | 0.140 |
Why?
|
| Internship and Residency | 2 | 2024 | 1049 | 0.130 |
Why?
|
| Neuroglia | 1 | 2017 | 166 | 0.130 |
Why?
|
| Disease Progression | 2 | 2021 | 2628 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 169 | 0.130 |
Why?
|
| Benzamides | 1 | 2017 | 203 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2018 | 321 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 301 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 484 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2367 | 0.110 |
Why?
|
| Female | 9 | 2025 | 68650 | 0.110 |
Why?
|
| Adult | 6 | 2024 | 35505 | 0.100 |
Why?
|
| Decompression, Surgical | 2 | 2022 | 96 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5429 | 0.090 |
Why?
|
| Diskectomy | 2 | 2022 | 21 | 0.090 |
Why?
|
| Middle Aged | 6 | 2023 | 31087 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2503 | 0.090 |
Why?
|
| Operating Rooms | 2 | 2023 | 116 | 0.080 |
Why?
|
| Male | 7 | 2025 | 63586 | 0.080 |
Why?
|
| Prognosis | 2 | 2025 | 3772 | 0.060 |
Why?
|
| Retina | 2 | 2018 | 283 | 0.060 |
Why?
|
| Superior Sagittal Sinus | 1 | 2023 | 4 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2025 | 283 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 108 | 0.050 |
Why?
|
| Laminectomy | 1 | 2022 | 29 | 0.050 |
Why?
|
| Unsupervised Machine Learning | 1 | 2022 | 18 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 138 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 210 | 0.040 |
Why?
|
| Cranial Sinuses | 1 | 2020 | 13 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2022 | 175 | 0.040 |
Why?
|
| Spine | 1 | 2022 | 160 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2025 | 596 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 244 | 0.040 |
Why?
|
| Pharyngeal Muscles | 1 | 2020 | 4 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 165 | 0.040 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 17 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 125 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 86 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 283 | 0.040 |
Why?
|
| Catheterization | 1 | 2020 | 176 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 123 | 0.040 |
Why?
|
| Microsurgery | 1 | 2019 | 70 | 0.040 |
Why?
|
| Reoperation | 1 | 2021 | 542 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 262 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 374 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 875 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 304 | 0.040 |
Why?
|
| Aged | 3 | 2023 | 22063 | 0.040 |
Why?
|
| Feeder Cells | 1 | 2017 | 3 | 0.040 |
Why?
|
| Microtomy | 1 | 2017 | 4 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 956 | 0.040 |
Why?
|
| Patient Selection | 1 | 2021 | 659 | 0.030 |
Why?
|
| Fibronectins | 1 | 2018 | 126 | 0.030 |
Why?
|
| Patient Safety | 1 | 2019 | 287 | 0.030 |
Why?
|
| Pain | 1 | 2022 | 788 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2020 | 253 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 869 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 318 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 2643 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 931 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 2675 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2017 | 454 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 896 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 723 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 2724 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 760 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 832 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 919 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 312 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 406 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 20409 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 347 | 0.030 |
Why?
|
| Child | 2 | 2025 | 20932 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 506 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 2013 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2774 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 1714 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 4891 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3968 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 9005 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3392 | 0.020 |
Why?
|
| Models, Biological | 1 | 2018 | 1717 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5423 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 16973 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 4087 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 10499 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3181 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 7150 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 12438 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 35334 | 0.020 |
Why?
|